January 23, 2018

ALEXANDRIA, Va. — CancerLinQ LLC and the American College of Medical Genetics and Genomics (ACMG), the medical specialty society for clinical and laboratory genetics professionals, have entered into a programmatic collaboration. CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform designed by oncologists for oncologists to leverage the power of big data to help improve the quality of care for patients with cancer, will benefit from the knowledge and expertise of ACMG leadership and members.

January 17, 2018

Alexandria, Va.—CancerLinQ LLC and the Association for Molecular Pathology (AMP), a global, molecular diagnostics professional society, have entered into a collaboration. AMP leadership and members will be applying the breadth of their knowledge to CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform designed to leverage the power of big data to help conquer cancer.

January 10, 2018

ALEXANDRIA, Va. — CancerLinQ LLC and the National Society of Genetic Counselors (NSGC), the professional society for genetic counselors, announced today that they have entered into a strategic alliance. With the collaboration, NSGC leaders and members will provide expertise to CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform aimed at improving the quality of cancer care using real-world cancer data.

December 21, 2017

ALEXANDRIA, Va. —  CancerLinQ LLC and the data services companies Tempus and Precision HealthAI announced today they have entered into an agreement that will accelerate development and delivery of high-quality, de-identified clinical databases for use by CancerLinQ®, its oncologist subscribers, partners, and the broader cancer community. The agreement will also enable CancerLinQ to more quickly build and expand on its core data sharing and quality improvement platform for oncology practices, and facilitate Tempus’ and Precision HealthAI’s connection to industry to support faster and better development of new treatments for patients. 

December 12, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC and DIA, (Drug Information Association), a global nonprofit association of health care product development professionals, announced today that they have entered into a programmatic partnership. Under the agreement, DIA will offer the scientific expertise of its members from the life sciences industry to help inform CancerLinQ’s development and rollout. CancerLinQ® is ASCO’s health information technology platform, developed by oncologists for oncologists, aimed at enhancing and improving the understanding and treatment of cancer.

September 14, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Southeastern Medical Oncology Center (SMOC) recently signed an agreement to participate in the CancerLinQ® platform, the first oncology practice in Eastern North Carolina to do so.

September 5, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that West Cancer Center in Tennessee has signed an agreement to participate in the CancerLinQ® platform. 

July 14, 2017

ALEXANDRIA, Va. — As part of a collaborative program between CancerLinQ LLC and the Oncology Nursing Society (ONS) aimed at helping oncology practices successfully incorporate electronic health record (EHR) data into clinical operations, three ONS members completed training in June to serve in the CancerLinQ® Ambassadors Pilot Program. CancerLinQ, a health information technology platform that powerfully connects and analyzes real-world cancer care data from almost any electronic record source, provides oncologists, nurses, and other practice staff with near real-time, actionable data to improve patient care processes and outcomes.

June 27, 2017

ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Ascension has signed an agreement to participate in the CancerLinQ® platform. Ascension, the largest non-profit health system in the United States, includes oncology care facilities throughout the country that can benefit from CancerLinQ’s growing quality network.

June 1, 2017

CHICAGO, Il. – CancerLinQ LLC today announced a long-term partnership with the U.S. Food and Drug Administration (FDA) that will harness cancer patient information and big data analytics to examine the real-world use of emerging and newly approved cancer therapies. Real-world data from CancerLinQ® will be used to grow the knowledge base about patterns of care across all cancer types and therapies, accelerate development of novel insights that might otherwise be challenging to obtain through standard research initiatives and data collection means, as well as potentially inform FDA regulatory strategy and decision-making processes.

June 1, 2017

CHICAGO, Il. – CancerLinQ LLC and the National Cancer Institute (NCI) today announced a partnership to facilitate the exchange of information between CancerLinQ® participating oncology practices and NCI’s Surveillance, Epidemiology, and End Results (SEER) program, one of the primary sources of data on cancer incidence and survival in the United States. The partnership aims to put valuable population-level cancer data at oncologists’ fingertips, while also strengthening the nation’s cancer surveillance efforts through a national data sharing collaboration.

May 31, 2017

ALEXANDRIA, VA.—CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), and the National Comprehensive Cancer Network® (NCCN®) announced today a collaboration to provide a link to the NCCN website for easy access to the NCCN Drugs & Biologics Compendium (NCCN Compendium®) within CancerLinQ®. This resource will support CancerLinQ® physicians and provides evidence-based guidance regarding the appropriate use of drugs and biologics in patients with cancer.

May 24, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC and the Society of Gynecologic Oncology (SGO) announced today a partnership where the SGO will provide expert guidance and insight on the management of gynecologic cancers for the CancerLinQ® platform. CancerLinQ LLC is a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO) that is developing and operating CancerLinQ®, a real-world, big data initiative focused on cancer patient medical information, aimed at improving the quality of patient care and outcomes. 

May 15, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Wendy S. Rubinstein, MD, PhD, FACMG, FACP, will be its first Division Director, Clinical Data Management and Curation. Rubinstein will oversee the team working to securely process and analyze the CancerLinQ® platform's patient data from millions of electronic health records to give personalized insights than can improve the quality of care for patients with cancer.

May 9, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO), and the College of American Pathologists (CAP) announced today that they will be partnering to bolster the expertise being provided to the CancerLinQ® platform, a real-world, big data initiative focused on cancer patient medical information, aimed at improving the quality of patient care and outcomes.

Pages